WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Cabergoline (Dostinex) is a prolactin-inhibitor tablet for hyperprolactinaemic disorders, supplied as 0.5 mg scored tablets in bottles that need no cold chain.

M Care Exports supplies cabergoline, including the originator Dostinex and Indian-made lines, to hospital pharmacies, licensed importers, distributors and tender authorities internationally, with established supply lanes into the GCC, Africa and Europe. If you are looking for Dostinex or cabergoline 0.5 mg tablets, send the destination, strength and quantity, and we quote per destination once the registration route and import licence are confirmed.

WhatsApp a cabergoline enquiry → Send enquiry by form
WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners Cold-chain validated (2–8°C & −25°C) CTD / eCTD dossier-ready ISO 9001:2015
Bulk supply and export terms

Cabergoline exporter and bulk supplier from India.

"We need a partner for Dostinex" is a typical enquiry, and buyers also type "dostinex price", "dostinex price in nigeria" and "dostinex 0.5mg price in nigeria". M Care Exports is a merchant-exporter and does not publish prices. We supply both originator or regulator-registered brands and Indian-made lines, so the first question is which you need. The UK emc lists Dostinex from Pfizer Limited alongside two cabergoline 0.5 mg products from other companies, and the US label lists Dostinex as 0.5 mg tablets in an 8-count bottle. Cabergoline is an oral tablet stored at room temperature, so there is no cold chain, and quotes turn on the line, pack, quantity, the destination's registration route and Incoterms. Our catalogue lists Indian-made 0.5 mg lines such as Cabgolin, Caberlin and Cabliz, and a 0.25 mg line, for destinations whose registration accepts them.

Source

WHO-GMP-certified Indian manufacturing line, named on every quote.

Minimum order

No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.

Pricing

On request. Indicative FOB or CIF quote, formal proforma on confirmation.

Incoterms

EXW, FOB, CIF, CIP or DAP.

Payment

Letter of credit (sight or usance) and telegraphic transfer.

Documentation

WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.

Shelf-life

Minimum remaining shelf-life agreed per order and confirmed on the proforma.

Response

Availability and CoPP status within two working days; pre-alert documents before dispatch.

Request a bulk quote → Send a bulk enquiry by form How bulk supply works
At a glance

Prolactin inhibitor (ATC G02CB03) for hyperprolactinaemic disorders, sourced and documented for export.

The UK SmPC gives cabergoline ATC code G02CB03 (prolactin inhibitors). The US Dostinex label (Pharmacia and Upjohn Company LLC, prescribing information revised 4/2025) lists 0.5 mg white, capsule-shaped tablets with a functional score, marked P and U either side of the breakline and engraved 700 on the opposite side, supplied as an 8-count bottle. Its indication is hyperprolactinemic disorders, idiopathic or due to pituitary adenomas, in adults. The UK SmPC (Pfizer Limited, text revised 09/2024) describes 0.5 mg tablets as flat, capsule-shaped, white, scored and 4 x 8 mm. It lists two indications: inhibition or suppression of physiological lactation, and treatment of dysfunctions associated with hyperprolactinaemia. The WHO Model List (2023) carries cabergoline tablets, 0.5 mg and 1 mg, under medicines for disorders of the pituitary hormone system, with bromocriptine as the therapeutic alternative.

Active ingredient

Cabergoline. Prolactin inhibitor (ATC G02CB03) for hyperprolactinaemic disorders.

Forms and strengths

0.5 mg scored tablet (Dostinex, US and UK labels); 0.25 mg tablet (Indian-made line in M Care catalogue).

Indications

Cabergoline (Dostinex) is an oral prolactin inhibitor for hyperprolactinaemic disorders. The US and UK Dostinex labels describe 0.5 mg scored tablets, and the M Care catalogue also lists Indian-made 0.25 mg and 0.5 mg lines.

Administration

Oral. Tablet.

Documentation

Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.

Who we supply

Hospital pharmacies, licensed importers and tender desks across our export markets.

India is our origin. We do not sell into the Indian market.

Buyers are hospital pharmacists in endocrinology and women's health, MoH and hospital tender desks, and licensed importers and distributors. Typical enquiries read "I'm looking for Dostinex 0.5 mg tablets for a hospital formulary" or "We need a partner for cabergoline 0.5 mg for a tender". M Care Exports supplies internationally, with established supply lanes into the GCC, Africa and Europe. Each destination sets its own route: in the UAE, product registration sits with the Emirates Drug Establishment (EDE), and elsewhere it sits with the national regulator, for example NAFDAC in Nigeria or the MHRA in the UK. Whether a given brand is registered, or needs an import licence or named-patient route, depends on the destination regulator, and M Care confirms it per enquiry.

GCC registration routes

Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.

MoH registration, GCC →

UK unlicensed routes

Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.

MHRA Specials →

Tender desks

Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.

Tender response →

Dossier support

CTD documentation from the sourcing manufacturer, compiled for your regulator's format.

Dossier preparation →

Pharmacist's note

What the dispensing pharmacist checks on cabergoline.

Check the dosing basis before you build a pack list, because the US and UK labels differ. The US label starts at 0.25 mg twice weekly and raises the dose by 0.25 mg twice weekly at intervals of no less than 4 weeks, to a maximum of 1 mg twice weekly. The UK SmPC starts hyperprolactinaemia at 0.5 mg per week, as one or two doses, with a usual therapeutic dosage of 1 mg per week within a range of 0.25 mg to 2 mg per week, and gives 1 mg as a single dose for inhibiting lactation. Both labels call for a cardiovascular evaluation, including an echocardiogram, before treatment (before long-term treatment in the UK SmPC), with echocardiographic monitoring during it. The US label contraindicates a history of pleural, pulmonary or retroperitoneal fibrotic disorders and warns about orthostatic hypotension and impulse control disorders. The US label says to avoid Dostinex for inhibiting or suppressing postpartum lactation. Storage is at room temperature, with no cold chain.

Regulatory & quality

The documentation pack a regulator actually asks for.

Cabergoline is a room-temperature oral solid. The US label gives storage at controlled room temperature, 20 to 25 degrees Celsius, in the original container. The UK Dostinex SmPC says not to store above 25 degrees Celsius and to keep the bottle tightly closed to protect from moisture, with a shelf life of 2 years and bottles of 2, 4 or 8 tablets, not all of which may be marketed. A UK generic SmPC from Aspire Pharma lists no special temperature storage condition and asks for storage in the original package to protect from light. Pack sizes and shelf life differ by product, so we confirm them per line before quoting. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator asks for it. We state the source of each line, originator or Indian-made, and make no claim for M Care itself beyond merchant-exporter documentation.

CoA and MoA, per batch

Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.

CoPP, WHO-GMP, MFG licence

Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.

CTD Module 3

Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.

Pack insert, labels, artwork

Destination-language patient information and labelling to the local regulator's standard, locked before shipment.

Pharmacovigilance

A named PV contact arranged in the destination market where the registration requires one.

How the enquiry works

Molecule · strength · volume · destination. One working day to a quote.

  1. Send us the specifics. Form and strength, pack preference, destination market and indicative volume for cabergoline.
  2. We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
  3. Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
  4. Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
  5. After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Frequently asked

Cabergoline supply, the specific questions.

What is the Dostinex price in Nigeria, and what sets it for an importer?

We do not publish prices, so we cannot give a figure for Dostinex in Nigeria. The landed price depends on whether you want the originator or an Indian-made cabergoline line, the strength (0.5 mg, or 0.25 mg on some lines), the pack and quantity, the registration route NAFDAC requires for the product, and Incoterms. Cabergoline is a room-temperature tablet, so cold-chain freight is not a cost driver. M Care Exports quotes per destination once you send the line, volume and country.

How much is Dostinex 0.5 mg, and why do quotes for the same strength differ?

M Care Exports gives no list price for Dostinex 0.5 mg. Quotes for the same 0.5 mg strength differ because originator and Indian-made lines are sourced differently, pack counts vary (the US label lists an 8-count bottle, and the UK SmPC lists bottles of 2, 4 or 8), and each destination has its own registration and import-licence requirements. Send the destination, line, pack and quantity and we quote against that specification.

Is there a generic of Dostinex, and what is the generic name?

The generic name is cabergoline. In the US, DailyMed lists cabergoline 0.5 mg tablets marketed under an abbreviated new drug application (ANDA). In the UK, the emc lists cabergoline 0.5 mg tablets from Aspire Pharma and from Aurobindo Pharma (Milpharm), alongside Dostinex from Pfizer Limited. Our catalogue also lists Indian-made lines, and whether a given line can enter your market depends on the destination regulator. M Care confirms which line suits your destination.

What is cabergoline used for, and is it licensed for lactation suppression?

The US Dostinex label lists hyperprolactinemic disorders, idiopathic or due to pituitary adenomas, in adults. The UK SmPC also lists inhibition or suppression of physiological lactation, but the US label says to avoid Dostinex for inhibiting or suppressing postpartum lactation. Indications therefore differ by country, and the label of your destination governs. We do not advise on clinical use.

What is the cabergoline dose, and why is there a 0.25 mg line?

The labels differ. The US label starts at 0.25 mg twice weekly and titrates by 0.25 mg twice weekly at intervals of no less than 4 weeks, to a maximum of 1 mg twice weekly. The UK SmPC starts hyperprolactinaemia at 0.5 mg per week in one or two doses, with a usual therapeutic dosage of 1 mg per week within a range of 0.25 mg to 2 mg per week. Our catalogue includes a 0.25 mg Indian-made line alongside the 0.5 mg lines, and whether it suits a destination depends on that market's registration. Dosing follows the destination label.

Does cabergoline need a cold chain, and what are the key safety warnings?

No. The US label says store at 20 to 25 degrees Celsius in the original container, and the UK Dostinex SmPC says do not store above 25 degrees Celsius. Both labels call for an echocardiogram to assess for valvular disease before treatment, and the UK SmPC frames this as before long-term treatment. The US label also warns of orthostatic hypotension and impulse control disorders, and contraindicates a history of pleural, pulmonary or retroperitoneal fibrotic disorders. The full label governs use.

Sources and review

Who stands behind this page, and where its statements come from.

Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.

This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.

Cabergoline enquiry

Send the specifics. You'll have a price inside one working day.

Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.

WhatsApp the Mumbai desk → Enquiry form Back to diabetes & endocrine